Skip to main content Help with accessibility Skip to main navigation

ADALIMUMAB injection (Humira®) in rheumatological conditions

CCG Approval Status:

Date Added: 11 - Apr - 2018
Body System:

The Pan Mersey Area Prescribing Committee recommends the prescribing of adalimumab injection (Humira®) for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and in patients fitting other criteria commissioned by Pan Mersey CCGs, as described.